CBL claim that if the merger is effected, the public will be harmed because Sparrow Hospital will no longer provide late re at the incipiency and block the merger. This court does not find irreparable injury will result from not enjoining the merger because this court sees a very minimal probability that a divestiture would ever be warranted in the future. For reasons that will be explained infra, this court is of the opinion that plaintiffs are not likely to succeed on the merits. Also, plaintiffs claim that if the merger is not enjoined they may lose standing to challenge it, thereby suffering irreparable harm. This court finds no merit in this contention. In making this argument, plaintiffs rely on the case of Arrow-Hart & Hegeman Electric 477, 97 S.Ct. 690, 50 L.Ed.2d 701 (1977) (<HOLDING>). For instance, as described above, GLASCCO and
holding that an antitrust injury is a necessary element of a  2 claim holding that plaintiff must show antitrust injury meaning injury of the type the antitrust laws were intended to prevent and which flows from defendants unlawful acts holding that an activity which is exempt from the antitrust laws cannot form the basis of an antitrust investigation holding that there must be a causal connection between the alleged antitrust violation and the antitrust injury for there to be antitrust standing holding that a plaintiff must show antitrust injury in order to bring an antitrust lawsuit